Victor Serebrov Email

Director . Entact Bio

Current Roles

Employees:
45
Revenue:
$3.5M
About
Entact Bio is a preclinical stage biotechnology company developing a new class of drugs that enhance the function of beneficial proteins. Launched by a founding team deeply rooted in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development, Entact has designed its proprietary Encompass™ platform to create enhancement-targeting chimeric (ENTAC™) medicines. ENTACs harness the ability of DUBs to regulate proteins. By leveraging this natural cellular mechanism to enhance protein function, Entact is expanding the universe of treatable diseases.
Entact Bio Address
65 grove St.
Watertown, MA
Entact Bio Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.